Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection

ConditionHELICOBACTER PYLORI INFECTIONS

Trial statusNot yet recruiting

Trial phasePhase 3

Trial typeInterventional

Biological sexAll

Age19+

SponsorTanta University

About this trial

this Study Evaluating Safety and Effectiveness of (Proton Pump Inhibitor versus Vonoprazan) Based Triple Therapy with or without Zinc to Eradicate H. pylori Infection

Eligibility criteria

Qualifiers

Age > 18.

Both males and females.

Patients who are positive for H.pylori infection by non-invasive Stool Antigen Test (SAT).

Disqualifiers

Prior H. pylori treatment: Previous treatment for H. pylori infection.

Allergies: Known allergies to study medications or components.

Patients cannot finish treatment course.

Pregnant and Lactating Women.

Trial design

Treatments tested in this trial

zinc sulfate
Vonoprazan + amoxicillin + clarithromycin
proton pump inhibitor + amoxicillin

Treatment groups

88 Participants

are divided into 4 treatment groups

Sponsors and collaborators

Tanta University

Lead sponsor

Source ClinicalTrials.gov